DISCLOSURE OF LARGE SHAREHOLDING – ROGER HOFSETH AND ASSOCIATED COMPANIES
Reference is made to the stock exchange announcements made by Aqua Bio Technology ASA ("ABT" or the "Company") on 21 August 2023 regarding the result of a subsequent offering (the "Subsequent Offering") and on 24 August 2023 regarding the Company convening a extraordinary general meeting (the "EGM") whereby the EGM, among other things, resolved the issuance of new shares in connection with the Subsequent Offering as further described therein (the "New Shares").
Following the issuance of the New Shares, and upon the registration of the corresponding share capital increases pertaining to the Private Placement and the Subsequent Offering and subsequent delivery of such New Shares, Roger Hofseth and associated companies, will hold a total of 9,225,426 shares in the Company, representing 19,46 % of the total number of shares and voting rights.
The disclosure obligation was triggered by Roger Hofseth and associated companies crossing below the 20 % threshold of total number of voting rights and shares in the Company due to dilution following the Subsequent Offering. The threshold was crossed on 21 August 2023.
This information is subject to the disclosure requirements pursuant to Sections 4-2 and 5-12 of the Norwegian Securities Trading Act.
Disclosure regulation
This information is subject of the disclosure requirements pursuant to section of 5-12 of the Norwegian Securities Trading Act.
Contacts
- Håvard Lindstrøm, 004794132288, hl@aquabiotech.no
About Aqua Bio Technology ASA
Aqua Bio Technology (ABT) is developing and commercializing sustainable
biotechnology for use in skin care products. ABT's cosmetics ingredients are
highly effective and they provide the cosmetics industry with natural
alternatives to traditional ingredients. ABT is also marketing and distributing
natural skin care products developed by partners towards consumers and
professional users. Aqua Bio Technology is listed on Euronext Expand.